RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Lumira Ventures
L

Lumira Ventures portfolio

Lumira Ventures has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Contraline's $92.5M Series B+ round in June 2026, alongside RA Capital Management, Invus, GV and 1 other. By category, its portfolio leans toward Health and bio (2). It has co-invested with RA Capital Management, GV and Invus, most often RA Capital Management (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 1.
Capital in their rounds: $267.5M.
Latest deal: Contraline · Jun 2, 2026.

What Lumira Ventures invests in

How Lumira Ventures invests

StageDealsCapital in rounds
Series B+ 2 100%$267.5M
YearDealsCapital in rounds
2024 1 50%$175M
2026 1 50%$92.5M

Share is of the 2 rounds on Recent Funding that name Lumira Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Lumira Ventures portfolio companies

CompanyRound with Lumira VenturesTotal raisedLatest raise
CContraline
Health and bio
 Series B+ · $92.5M$105.45MJun 2, 2026
Series B+
AAlpha-9 Oncology
Health and bio
 Series B+ · $175M$175MOct 23, 2024
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Lumira Ventures, which is a subset of its real portfolio. API: /api/v1/investors/lumira-ventures (get a free API key). More: the most active VC firms and new venture capital funds.